LEAP-2
Information
Antimicrobial Peptide in Human Blood Ultrafiltrate
One methods aimed at finding peptides and proteins, is the systematic analysis of
polypeptides in human blood ultrafiltrate, which has proven to be successful. Liver-expressed
antimicrobial peptide 1 (LEAP-1)/hepcidin (Code 4392-s) is an example of such, which elicits
antimicrobial activity as well as some functions in iron homeostasis. Following LEAP-1, a new
cationic peptide termed LEAP-2 has recently discovered by using this same method, the "peptide
trapping" approach [Protein Sci., 12, 143 (2003)].
The isolated peptides have variable chain length with the deletion of the longest peptide,
composed of 40 amino acid residues, at both the amino- and carboxyl-termini. Its disulfide
arrangement was determined to be Cys1-Cys3 and Cys2-Cys4 (Cys numbering from the amino-
terminus) by analyzing the molecular weight and sequence of the tryptic fragments. The cDNA
cloning of LEAP-2 reveals the precursor of LEAP-2 to be a 77-residue peptide, in which the longest
form corresponds to the residues between the positions of 38 and 77 in the precursor [prepro-
LEAP-2(38-77)]. The primary structures of LEAP-2 of rhesus monkey, cow, pig, mouse, and
guinea pig were also determined, and found to be highly conserved among these species.
LEAP-2 mRNA is predominantly expressed in liver and small intestine.
Liver-Expressed Antimicrobial Peptide 2 (Human)¡§
Met-Thr-Pro-Phe-Trp-Arg-Gly-Val-Ser-Leu-
Arg-Pro-Ile-Gly-Ala-Ser-Cys-Arg-Asp-Asp-
Ser-Glu-Cys-Ile-Thr-Arg-Leu-Cys-Arg-Lys-
Arg-Arg-Cys-Ser-Leu-Ser-Val-Ala-Gln-Glu
(Disulfide bonds between Cys17-Cys28 and Cys23-Cys33)
LEAP-2 [preproLEAP-2 (38-77)] exerts antibacterial activities against Gram-positive,
Gram-negative bacteria, and yeast (IC50 value was around 5 mM against Saccharomyces. cerevisiae).
Interestingly, the amino-terminally truncated form, prepro-LEAP-2 (44-77), has not affected the
viability of the germs tested. This 40 amino acid residue peptide, LEAP-2, has been reported to be
circulating in human blood. LEAP-2 should prove to be varuable in studying its role in self-defense
in humans, as well as its role as an antibacterial peptide in the family of the well-established
a-/b-defensins.
| Code |
Compound |
Package |
Price(Yen) |
| 4405-s |
Liver-Expressed Antimicrobial Peptide 2 (Human) |
0.1 mg vial |
22,000 |
Related Products
| Code |
Compound |
Package |
Price(Yen) |
| 4392-s |
Liver-Expressed Antimicrobial Peptide 1 (Human) |
0.1 mg vial |
18,000 |